ERBB2 and breast neoplasm: This mechanism, which is observed in breast CAFs, as well as in luminal B (BT-474) and triple-negative (MDA-MB-231) breast cancer cells, but not in HER2 (SK-BR-3) and luminal A (MCF7) tumor cells, may contribute to angiogenesis in breast tumors [126].